Home - Products - Others - Other Targets - 6-Hydroxyluteolin 7-glucoside

6-Hydroxyluteolin 7-glucoside

CAS No. 54300-65-1

6-Hydroxyluteolin 7-glucoside( —— )

Catalog No. M29082 CAS No. 54300-65-1

6-Hydroxyluteolin 7-glucoside is derived from Tanacetum parthenium and T. vulgare showing anti-inflammatory effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 377 In Stock
5MG 332 In Stock
10MG 534 In Stock
25MG 845 In Stock
50MG 1107 In Stock
100MG 1479 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    6-Hydroxyluteolin 7-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Hydroxyluteolin 7-glucoside is derived from Tanacetum parthenium and T. vulgare showing anti-inflammatory effects.
  • Description
    6-Hydroxyluteolin 7-glucoside is derived from Tanacetum parthenium and T. vulgare showing anti-inflammatory effects.(In Vitro):6-Hydroxyluteolin 7-glucoside inhibits the major pathways of arachidonate metabolism in leukocytes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    54300-65-1
  • Formula Weight
    464.379
  • Molecular Formula
    C21H20O12
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (215.34 mM)
  • SMILES
    OC[C@H]1O[C@@H](Oc2cc3oc(cc(=O)c3c(O)c2O)-c2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • VPC-18005

    VPC-18005 is a luciferase inhibitor. VPC-18005 inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain thereby disrupting the ERG binding to DNA.

  • VL9, RT, (346 - 354)

    VL9, RT, (346 - 354)

  • Talacotuzumab

    Talacotuzumab (JNJ 56022473) is an IgG1 fully humanized CD123 neutralizing monoclonal antibody containing a modified Fc structure.